Free Trial

Natera (NTRA) Stock Price, News & Analysis

Natera logo
$147.57 -2.28 (-1.52%)
As of 01:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Natera Stock (NASDAQ:NTRA)

Key Stats

Today's Range
$146.84
$151.09
50-Day Range
$149.40
$171.87
52-Week Range
$92.14
$183.00
Volume
523,553 shs
Average Volume
1.42 million shs
Market Capitalization
$20.15 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$184.63
Consensus Rating
Buy

Company Overview

Natera Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
32nd Percentile Overall Score

NTRA MarketRank™: 

Natera scored higher than 32% of companies evaluated by MarketBeat, and ranked 774th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Natera has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 15 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Natera has only been the subject of 3 research reports in the past 90 days.

  • Read more about Natera's stock forecast and price target.
  • Earnings Growth

    Earnings for Natera are expected to grow in the coming year, from ($1.49) to ($1.25) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Natera is -100.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Natera is -100.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Natera has a P/B Ratio of 16.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Natera's valuation and earnings.
  • Percentage of Shares Shorted

    5.03% of the float of Natera has been sold short.
  • Short Interest Ratio / Days to Cover

    Natera has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Natera has recently increased by 1.60%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Natera does not currently pay a dividend.

  • Dividend Growth

    Natera does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.03% of the float of Natera has been sold short.
  • Short Interest Ratio / Days to Cover

    Natera has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Natera has recently increased by 1.60%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Natera has a news sentiment score of 1.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Natera this week, compared to 15 articles on an average week.
  • Search Interest

    Only 3 people have searched for NTRA on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Natera to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Natera insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,345,368.00 in company stock.

  • Percentage Held by Insiders

    Only 7.60% of the stock of Natera is held by insiders.

  • Percentage Held by Institutions

    99.90% of the stock of Natera is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Natera's insider trading history.
Receive NTRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natera and its competitors with MarketBeat's FREE daily newsletter.

NTRA Stock News Headlines

Natera, Inc. (NTRA): A Bull Case Theory
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Should You Invest in Natera (NTRA)?
See More Headlines

NTRA Stock Analysis - Frequently Asked Questions

Natera's stock was trading at $158.30 at the beginning of 2025. Since then, NTRA stock has decreased by 6.2% and is now trading at $148.5180.

Natera, Inc. (NASDAQ:NTRA) released its earnings results on Thursday, May, 8th. The medical research company reported ($0.50) earnings per share for the quarter, topping the consensus estimate of ($0.59) by $0.09. The firm's revenue was up 36.5% on a year-over-year basis.
Read the conference call transcript
.

Natera (NTRA) raised $101 million in an initial public offering on Thursday, July 2nd 2015. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. Morgan Stanle, Cowen and Company and Piper Jaffray acted as the underwriters for the IPO and Baird and Wedbush Pacgrow were co-managers.

Natera's top institutional investors include Zevenbergen Capital Investments LLC (0.30%), Assenagon Asset Management S.A. (0.16%), Exchange Traded Concepts LLC and HWG Holdings LP (0.03%). Insiders that own company stock include Roelof Botha, Matthew Rabinowitz, Daniel Rabinowitz, Steven Leonard Chapman, John Fesko, Solomon Moshkevich, Michael Burkes Brophy, Herm Rosenman, Jonathan Sheena, James Healy, Gail Boxer Marcus, Rowan E Chapman and Robert Alan Schueren.
View institutional ownership trends
.

Shares of NTRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Natera investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
5/08/2025
Today
7/16/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:NTRA
CIK
1604821
Fax
N/A
Employees
4,434
Year Founded
N/A

Price Target and Rating

High Price Target
$251.00
Low Price Target
$125.00
Potential Upside/Downside
+23.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.47)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$190.43 million
Net Margins
-10.36%
Pretax Margin
-10.34%
Return on Equity
-18.29%
Return on Assets
-11.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.87
Quick Ratio
3.74

Sales & Book Value

Annual Sales
$1.70 billion
Price / Sales
12.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.05 per share
Price / Book
16.56

Miscellaneous

Outstanding Shares
136,550,000
Free Float
126,169,000
Market Cap
$20.46 billion
Optionable
Optionable
Beta
1.73

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:NTRA) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners